StartsidaBBN • SWX
add
Bellevue Group AG
Föregående stängning
14,75 CHF
Dygnsintervall
14,50 CHF - 14,80 CHF
Årsintervall
11,05 CHF - 24,30 CHF
Börsvärde
195,19 mn CHF
Genomsnittlig volym
9,95 tn
P/E-tal
13,08
Direktavkastning
7,93 %
Primär börs
SWX
Ekonominyheter
Ekonomi
Resultaträkning
Intäkter
Nettoinkomst
(CHF) | juni 2024info | Förändring Y/Y |
---|---|---|
Intäkter | 18,41 mn | −11,31 % |
Rörliga kostnader | 13,73 mn | −10,56 % |
Nettoinkomst | 3,72 mn | −7,22 % |
Nettovinstmarginal | 20,18 | 4,61 % |
Vinst per aktie | — | — |
EBITDA | — | — |
Giltig skattesats | 17,26 % | — |
Balansräkning
Totala tillgångar
Totala ansvarsskyldigheter
(CHF) | juni 2024info | Förändring Y/Y |
---|---|---|
Kontanta och kortsiktiga investeringar | 30,49 mn | 100,63 % |
Totala tillgångar | 138,75 mn | −4,69 % |
Totala ansvarsskyldigheter | 22,05 mn | −24,81 % |
Totala tillgångar | 116,70 mn | — |
Utestående aktier | 13,20 mn | — |
P/B | 1,67 | — |
Avkastning på tillgångar | 10,71 % | — |
Avkastning på kapital | — | — |
Kassaflöde
Förändring i nettokassa
(CHF) | juni 2024info | Förändring Y/Y |
---|---|---|
Nettoinkomst | 3,72 mn | −7,22 % |
Kontanter från verksamhet | 3,65 mn | 137,31 % |
Kontanter från investering | — | — |
Kontanter från finansiering | −8,10 mn | 45,85 % |
Förändring i nettokassa | −4,17 mn | 83,13 % |
Fritt kassaflöde | — | — |
Om
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021.
Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
Grundades
1993
Hemsida
Anställda
88